Moleculin Biotech Inc (NASDAQ: MBRX): Stock That Needs Special Handling
Geode Capital Management LLC recently announced the acquisition of new stake in Moleculin Biotech Inc (NASDAQ:MBRX). The institutional investor has increased its shareholding in the Healthcare company by 0.09% to 0.25 million shares with purchase of 219.0 shares. This fresh investment now brings its stake to 0.83% valued currently at $0.15 million. In addition, BlackRock […]
